ZNF274 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.010000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.313600E-01
Normal-vs-Stage2
6.283400E-01
Normal-vs-Stage3
3.149200E-01
Normal-vs-Stage4
7.839800E-01
Stage1-vs-Stage2
1.838440E-01
Stage1-vs-Stage3
9.757000E-01
Stage1-vs-Stage4
1.225990E-01
Stage2-vs-Stage3
2.874000E-01
Stage2-vs-Stage4
4.700800E-01
Stage3-vs-Stage4
1.863370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.967200E-01
Normal-vs-AfricanAmerican
3.556600E-01
Normal-vs-Asian
5.237800E-01
Caucasian-vs-AfricanAmerican
5.301600E-01
Caucasian-vs-Asian
8.223000E-01
AfricanAmerican-vs-Asian
6.187000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.271400E-01
Normal-vs-Female
5.711800E-01
Male-vs-Female
3.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.739000E-01
Normal-vs-Age(41-60Yrs)
6.769400E-01
Normal-vs-Age(61-80Yrs)
5.768800E-01
Normal-vs-Age(81-100Yrs)
5.471000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.372600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.187800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.938600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.734160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.553600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.788400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.815400E-01
Normal-vs-Daily Drinker
4.936000E-01
Normal-vs-Weekly Drinker
3.485800E-01
Normal-vs-Occasional Drinker
8.084800E-01
Normal-vs-Social Drinker
5.454200E-01
Non Drinker-vs-Daily Drinker
8.951400E-01
Non Drinker-vs-Weekly Drinker
2.986200E-01
Non Drinker-vs-Occasional Drinker
1.018320E-02
Non Drinker-vs-Social Drinker
4.264000E-01
Daily Drinker-vs-Weekly Drinker
3.640800E-01
Daily Drinker-vs-Occasional Drinker
1.440300E-02
Daily Drinker-vs-Social Drinker
6.094400E-01
Weekly Drinker-vs-Occasional Drinker
1.825640E-01
Weekly Drinker-vs-Social Drinker
6.424600E-01
Occasional Drinker-vs-Social Drinker
4.799800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.260000E-01
Normal-vs-Grade 2
4.597500E-02
Normal-vs-Grade 3
3.384200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.520000E-02
Grade 1-vs-Grade 3
3.628500E-02
Grade 1-vs-Grade 4
1.260000E-01
Grade 2-vs-Grade 3
4.765800E-01
Grade 2-vs-Grade 4
4.597500E-02
Grade 3-vs-Grade 4
3.384200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.725600E-01
Normal-vs-NonDiabetic
6.032800E-01
Diabetic-vs-NonDiabetic
6.732400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.315000E-01
Normal-vs-NoPancreatitis
6.072000E-01
Pancreatitis-vs-NoPancreatitis
9.863600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.949800E-01
Normal-vs-N1
6.035800E-01
N0-vs-N1
8.878800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.348200E-01
Normal-vs-TP53-NonMutant
5.582200E-01
TP53-Mutant-vs-TP53-NonMutant
4.478900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
